TrustCore Financial Services’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$30.8K Hold
510
﹤0.01% 542
2022
Q3
$38K Hold
510
﹤0.01% 496
2022
Q2
$58K Sell
510
-333
-40% -$39.1K 0.01% 424
2022
Q1
$160K Buy
843
+333
+65% +$77.1K 0.01% 302
2021
Q4
$177K Hold
510
0.02% 263
2021
Q3
$171K Buy
+510
New +$262K 0.02% 286

Other funds holding OMIC

TrustCore Financial Services's OMIC Position: Q4 2022 in Review

TrustCore Financial Services held its Singular Genomics Systems, Inc. Common Stock (OMIC) position steady in Q4 2022 at 510 shares worth $30.8K. The position accounts for ﹤0.01% of the portfolio, ranked #542.

TrustCore Financial Services first reported a position in OMIC in Q3 2021 and has held it in 6 quarters since. The position peaked at $177K in Q4 2021. 80 funds tracked by Wall St. Rank hold OMIC as of Q4 2022.

  • TrustCore Financial Services held 510 shares of Singular Genomics Systems, Inc. Common Stock worth $30.8K as of Q4 2022.
  • TrustCore Financial Services left its Singular Genomics Systems, Inc. Common Stock share count unchanged in Q4 2022.
  • Singular Genomics Systems, Inc. Common Stock made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #542 holding.
  • TrustCore Financial Services first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2021 and has held it in 6 quarters since.
  • TrustCore Financial Services's Singular Genomics Systems, Inc. Common Stock position peaked at $177K in Q4 2021.
  • 80 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.